Blueshift Asset Management, LLC Spring Works Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $152,369 - $498,520	-8,299 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$48.97 - $65.46 $406,402 - $543,252	8,299 New	8,299 $468,000
Q3 2021 Nov 12, 2021	SELL	$62.66 - $88.26 $368,566 - $519,145	-5,882 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $396,740 - $503,675	5,882 New	5,882 $485,000
Q1 2021 May 06, 2021	SELL	$65.1 - $93.59 $312,545 - $449,325	-4,801 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $232,176 - $374,093	4,801 New	4,801 $348,000

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.